FDA approves medication for sleep apnea
The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...
HealthDay on MSN23h
Sleep Apnea Surgery Linked to Lower Risk for Car Accidents for Patients
For patients with obstructive sleep apnea (OSA), sleep surgery is associated with a significantly reduced risk for motor vehicle accidents (MVA) compared with continuous positive airway pressure (CPAP ...
Future Market Insights9h
Sleep Apnea Devices Market to Reach USD 20.4 Billion by 2033 at a 9.5% of CAGR, Amid Rising Awareness and Technological Advancements
The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...